Research output per year
Research output per year
International and National Collaboration
Publications and projects within past five years.
-
Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia
Hohtari, H., Pallisgaard, N., Kankainen, M., Ellonen, P., Brück, O., Siitonen, T., Säily, M., Sinisalo, M., Pyörälä, M., Itälä-Remes, M., Koskenvesa, P., Elonen, E., Mustjoki, S. & Porkka, K., Aug 2022, In: Haematologica. 107, 8, p. 1971-1976 6 p.Research output: Contribution to journal › Letter › Scientific
Open AccessFile -
Epigenetic modifier gene mutations in chronic myeloid leukemia (CML) at diagnosis are associated with risk of relapse upon treatment discontinuation
Awad, S. A., Brück, O., Shanmuganathan, N., Järvinen, T., Lähteenmäki, H., Klievink, J., Ibrahim, H., Kytölä, S., Koskenvesa, P., Hughes, T. P., Branford, S., Kankainen, M. & Mustjoki, S., 20 Apr 2022, In: Blood cancer journal. 12, 4, 4 p., 69.Research output: Contribution to journal › Letter › Scientific
Open AccessFile -
IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia
Huuhtanen, J., Ilander, M., Yadav, B., Dufva, O. M. J., Lähteenmäki, H., Kasanen, T., Klievink, J., Olsson-Strömberg, U., Stentoft, J., Richter, J., Koskenvesa, P., Hoglund, M., Söderlund, S., Dreimane, A., Porkka, K., Gedde-Dahl, T., Gjertsen, B. T., Stenke, L., Myhr-Eriksson, K., Markevarn, B., & 6 others, 1 Sep 2022, In: Journal of Clinical Investigation. 132, 17, 17 p., 152585.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Long-term tolerability and efficacy after initial PegIFN-alpha addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study
Flygt, H., Söderlund, S., Stentoft, J., Richter, J., Koskenvesa, P., Mustjoki, S., Majeed, W., Lubking, A., Dreimane, A., Markevarn, B., Stenke, L., Myhr Eriksson, K., Gjertsen, B. T., Gedde-Dahl, T., Dimitrijevic, A., Udby, L., Olsson-Stromberg, U. & Hjorth-Hansen, H., Dec 2021, In: European Journal of Haematology. 107, 6, p. 617-623 7 p.Research output: Contribution to journal › Article › Scientific › peer-review
Open AccessFile -
Molecular status 36 months after TKI discontinuation in CML is highly predictive for subsequent loss of MMR-final report from AFTER-SKI
Richter, J., Lubking, A., Soderlund, S., Lotfi, K., Markevarn, B., Sjalander, A., Stenke, L., Deneberg, S., Ahlstrand, E., Myhr-Eriksson, K., Panayiotidis, P., Gedde-Dahl, T., Zackova, D., Mayer, J., Olsson-Stromberg, U., Mahon, F-X., Saussele, S., Hjorth-Hansen, H. & Koskenvesa, P., Aug 2021, In: Leukemia. 35, 8, p. 2416-2418 3 p.Research output: Contribution to journal › Letter › Scientific
Open AccessFile
Press/Media
-
Minulla todettiin: Krooninen myelooinen leukemia
15/04/2015
1 Media contribution
Press/Media: Press / Media